BG medicine - BGMT - Buyout Galectin-3

Potential takeover in light of the recent price change from CMS- Galectin 3 test

 

Possible, they have a strong relationship with Abbott and few other industry leaders.
Wouldn't surprise me

 

Looks like something surely is cooking here. Lids about to open and it's stock is about to explode here.
Don't know about a buyout but anything is possible in this Bio world. Nevertheless the company looks like a solid investment and should be profitable this year.
The CMS price adjustment will pay off not to mention what they have in the back burner.
Happy investing

 

$3-4 short term and I mean short term
Enjoy

 

Their cardioscore will certainly make some noise as well.
I hear they are very close with Abbott re Galectin
Definitely trading at a discount and it will not be for much longer

 

CMS adjustment automatically accounts for a 70% increase in revenues. Galectin 3 is just now gaining traction and I can see revenues doubling easily year over year. The valuation here is very tempting for a larger entity to scoop them up and take advantage of what BG has to offer

 

Looks good

 

Lots going on, they did mention some substantial milestone payments a while back right. Would only make sense given how cheap their valuation is

Last call, Sohmer indicated"- Abbott Diagnostics' resubmission of an automated ARCHITECT Galectin-3 assay to the FDA for 510(k) clearance, noting that this was on track to be completed by year end"
THEN he said "by year end to complete a medical review of data generated in support of its previous 510(k) submission to FDA for its CardioScore"

 

Been following the developments here, Question- they have a fairly small float, cash on hand, market cap is peanuts and their galectin 3 is on pace for what? 2-3 million per quarter.
So I ask, why is this being manipulated and held this low?